Pharmacokinetics of luteolin and tetra-acetyl-luteolin assayed by HPLC in rats after oral administration

Biomedical Chromatography

Volumn 24, Issue 8, 2010, Pages 826-832

  Chen, Xiujie ^a,b   Liu, Lei ^b   Sun, Zhizhong ^c   Liu, Yongsheng ^b   Xu, Jiankai ^b   Liu, Sibo ^a   Huang, Bangqing ^b   Ma, Ling ^b   Yu, Zhiguo ^a   Bi, Kaishun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c HEILONGJIANG UNIVERSITY   (China)

Author keywords

HPLC; Luteolin; Pharmacokinetics; Rats; Tetra acetyl luteolin

Indexed keywords

BINARY MIXTURES; FLAVONOIDS; PHARMACOKINETICS;

AGILENT; GLACIAL ACETIC ACID; HPLC; HPLC METHOD; LUTEOLIN; METHANOL-WATER; MOBILE PHASIS; ORAL ADMINISTRATION; RAT PLASMA; TETRA-ACETYL-LUTEOLIN;

RATS;

LUTEOLIN; TETRAACETYLLUTEOLIN; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; CALIBRATION; COMPARTMENT MODEL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PLASMA; QUANTITATIVE ANALYSIS; RAT; SINGLE DRUG DOSE; ULTRAVIOLET RADIATION; ANIMAL; CHEMISTRY; EVALUATION STUDY; MALE; PROCEDURES; WISTAR RAT;

RATTUS; TETRA;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LUTEOLIN; MALE; RATS; RATS, WISTAR;

EID: 77954728470     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1370     Document Type: Article

References (14)

1. Brusselmans K, Vrolix R, Verhoeven G and Swinnen JV. Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. Journal of Biological Chemistry 2005; 280: 5636-5645. (Pubitemid 40280043)
2. Chen HQ, Jin ZU, Wang XJ, Xu XM, Deng L and Zhao JW. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neuroscience Letters 2008; 448: 175-179.
3. Ferriola PC, Cody V and Middleton E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochemical Pharmacology 1989; 38: 1617-1624.
4. Hougee S, Sanders A, Faber J, Graus YM, van den Berg WB, Garssen J, Smit HF and Hoijer MA. Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin chrysin, due to selective elimination of monocytes/ macrophages. Biochemical Pharmacology 2005; 69: 241-248.
5. Leung HW, Kuo CL, Yang WH, Lin CH and Lee HZ. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. European Journal of Pharmacology 2006; 534: 12-18.
6. Lv PC, Li HQ, Xue JY, Shi L and Zhu HL. Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents. European Journal of Medicinal Chemistry 2009; 44: 908-914.
7. Manju V and Nalini N. Protective role of luteolin in 1, 2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochemistry and Function 2007; 25: 189-194.
8. Samejima K, Kanazawa K, Ashida H and Danno G. Luteolin: a strong antimutagen against dietary carcinogen, Trp-P-2, in peppermint, sage, and thyme. Journal of Agricultural and Food Chemistry 1995; 43: 410-414.
9. Seelinger G, Merfort I and Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Medica 2008; 74: 1667-1677.
10. Shimoi K, Okadaa H, Furugoria M, Godaa T, Takasea S, Suzukib M, Harab Y, Yamamotoc H and Kinaea N. Intestinal absorption of luteolin and luteolin 7-O-L-glucoside in rats and humans. FEBS Letters 1998; 438: 220-224.
11. Shimoi K, Saka N, Nozawa R, Sato M, Amano I, Nakayama T and Kinae N. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metabolism and Disposition 2001; 29: 1521-1524. (Pubitemid 33111582)
12. Woodman OL, Meeker WF, Boujaoude M. Vasorelaxant and antioxidant activity of flavonols and flavones: structure-activity relationships. Journal of Cardiovascular Pharmacology and Therapeutics 2005; 46: 302-309. (Pubitemid 41262832)
13. Yang DJ, Li YM, Chen SL and Chen XZ. Puerarin derivatives and their medical uses. China patent: 200410096209.9, 2004.
14. Yang SF, Yang WE, Chang HR, Chu SC and Hsieh YS. Luteolin induces apoptosis in oral squamous cancer cells. Journal of Dental Research 2008; 87: 401-406.